secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2024-08-30T23:59:59+00:00
Accession:  0001297184-24-000051
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Amphastar subsidiary enters exclusive Primatene MIST distribution deal for Greater China; est. $10M over 10 yrs
--------------------------------------------------------------------------------

- Armstrong (Amphastar subsidiary) appoints Genreach as exclusive distributor for Primatene MIST in Mainland China, Taiwan, Hong Kong, Macau; 10-year term.
- Estimated total revenue to Amphastar over 10 years is ~$10 million, subject to currency exchange adjustments.
- Genreach is responsible for obtaining all regulatory approvals in the region.
- Related-party transaction: CEO Jack Zhang and Chairman Mary Luo beneficially own majority of Hanxin, Genreach's parent.
- Minimum purchase amounts per contract year; profit sharing based on Genreach's per unit net revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000129718424000051/0001297184-24-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000129718424000051/amph-20240828x8k.htm
  HTML page:      https://secwatch.observer/filing/0001297184-24-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer